Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly dividing de‐differentiated state
Abstract Treatment of BRAF‐mutant melanomas with MAP kinase pathway inhibitors is paradigmatic of the promise of precision cancer therapy but also highlights problems with drug resistance that limit patient benefit. We use live‐cell imaging, single‐cell analysis, and molecular profiling to show that...
Saved in:
| Main Authors: | Mohammad Fallahi‐Sichani, Verena Becker, Benjamin Izar, Gregory J Baker, Jia‐Ren Lin, Sarah A Boswell, Parin Shah, Asaf Rotem, Levi A Garraway, Peter K Sorger |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2017-01-01
|
| Series: | Molecular Systems Biology |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/msb.20166796 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A diaryl urea derivative, SMCl inhibits cell proliferation through the RAS/RAF/MEK/ERK pathway in hepatocellular carcinoma
by: Yue Fu, et al.
Published: (2025-07-01) -
Dayuan Yin alleviates symptoms of HCoV-229E-induced pneumonia and modulates the Ras/Raf1/MEK/ERK pathway
by: Rui Li, et al.
Published: (2024-11-01) -
Vemurafenib resistant melanoma cells acquire mesenchymal stem cell-like properties
by: A. A. Vartanian, et al.
Published: (2019-12-01) -
TREATMENT OF <em>BRAF</em><sup>V600E</sup> POSITIVE ANAPLASTIC THYROID CARCINOMA: CASE REPORT
by: P. A. Nikiforovich, et al.
Published: (2020-10-01) -
Cutaneous metastasis of cecum cancer with MSI-high and BRAFV600E mutation: a case report
by: Kosuke Yunoki, et al.
Published: (2021-08-01)